Publication | Open Access
PAX6 maintains β cell identity by repressing genes of alternative islet cell types
156
Citations
61
References
2016
Year
Tf Pax6Cell SpecializationCellular PhysiologyInsulin SignalingMetabolic SyndromeTranscriptional RegulationCellular Regulatory MechanismMetabolic SignalingCell SignalingMolecular SignalingMolecular PhysiologyInsulin Managementβ Cell FailureGene ExpressionEpigenetic RegulationCell BiologyMolecular MedicineSignal TransductionDevelopmental BiologyNatural SciencesDiabetesMetabolic RegulationDiabetes Mellitusβ Cell IdentityMedicineCell Developmentβ Cells
Type 2 diabetes is thought to involve a compromised β cell differentiation state, but the mechanisms underlying this dysfunction remain unclear. Here, we report a key role for the TF PAX6 in the maintenance of adult β cell identity and function. PAX6 was downregulated in β cells of diabetic db/db mice and in WT mice treated with an insulin receptor antagonist, revealing metabolic control of expression. Deletion of Pax6 in β cells of adult mice led to lethal hyperglycemia and ketosis that were attributed to loss of β cell function and expansion of α cells. Lineage-tracing, transcriptome, and chromatin analyses showed that PAX6 is a direct activator of β cell genes, thus maintaining mature β cell function and identity. In parallel, we found that PAX6 binds promoters and enhancers to repress alternative islet cell genes including ghrelin, glucagon, and somatostatin. Chromatin analysis and shRNA-mediated gene suppression experiments indicated a similar function of PAX6 in human β cells. We conclude that reduced expression of PAX6 in metabolically stressed β cells may contribute to β cell failure and α cell dysfunction in diabetes.
| Year | Citations | |
|---|---|---|
Page 1
Page 1